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Background-—Recent estimates of the global burden of rheumatic heart disease (RHD) have highlighted the paucity of reliable RHD
mortality data from populations most affected by RHD.
Methods and Results-—We investigated RHD mortality rates and trends for Indigenous and non-Indigenous Australians in the
Northern Territory (NT) for the period 1977–2005 and seminationally (NT plus 4 other states, covering 89% of Indigenous
Australians) from 1997 to 2005 using vital statistics data. All analysis was undertaken by Indigenous status, sex, and age at death.
In the NT, 90% of all deaths from RHD were among Indigenous persons; however, the Indigenous population makes up only 30.4%
of the NT population. The death rate ratio (Indigenous compared with non-Indigenous) was 54.80 in the NT and 12.74 in the other 4
states (estimated at the median age of 50 years). Non-Indigenous death rates were low for all age groups except ≥65 years,
indicating RHD deaths in the elderly non-Indigenous population. Death rates decreased at a more rapid rate for non-Indigenous
than Indigenous persons in the NT between 1997 and 2005. Indigenous persons in other parts of Australia showed lower death
rates than their NT counterparts, but the death rates for Indigenous persons in all states were still much higher than rates for non-
Indigenous Australians.
Conclusions-—Indigenous Australians are much more likely to die from RHD than other Australians. Among the Indigenous
population, RHD mortality is much higher in the NT than elsewhere in Australia, exceeding levels reported in many industrialized
countries more than a century ago. With the paucity of data from high-prevalence areas, these data contribute substantially to
understanding the global burden of RHD mortality. ( J Am Heart Assoc. 2015;4:e001282 doi: 10.1161/JAHA.114.001282)
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R heumatic heart disease (RHD) is a disease of socialdisadvantage and deprivation. Over the past 60 years
there have been impressive declines in the prevalence of RHD
throughout the industrialized world, including Australia, mainly
as a result of improvements in socioeconomic conditions
(including reduced household crowding) and access to health
services. These improvements have yet to be seen in many
developing countries and in Indigenous populations in devel-
oped countries. Indigenous populations in developed coun-
tries frequently live in deprived settings and face issues of
lower living standards similar to populations in developing
countries.1
An RHD systematic review done as part of the Global
Burden of Disease Study 2010 found very few RHD mortality
data sets available globally, and only 4 countries—Australia,
New Zealand, India, and Ethiopia—had any recent population-
based data.2–6 Attempts to determine global RHD mortality
have relied on mathematical models to infer global estimates
using data either from the United States in the 1950s7 or
from the above 4 countries.8 Australia is one of the few
settings with a high-RHD-incidence population (Indigenous
Australians) that also has access to good cause-speciﬁc
mortality data, which could assist with global understanding
of RHD mortality in the 21st century. Nonetheless, there are
few data with which to examine mortality in the Indigenous
population and only a limited number of reports examining
RHD mortality internationally.4,9–11
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Indigenous Australians make up 2.5% of the total
Australian population; live predominantly in conditions of
social, economic, and environmental disadvantage; and often
have poor health status compared with non-Indigenous
Australians. Life expectancy of Aboriginal and Torres Strait
Islander men is estimated to be 10.6 years lower than that of
non-Indigenous men, and life expectancy of Aboriginal and
Torres Strait Islander women is 9.5 years lower than that of
non-Indigenous women.12 Approximately 89% of the total
Australian Indigenous population lives in 5 states of Australia:
the Northern Territory (NT), Queensland, South Australia,
Western Australia, and New South Wales. The NT population
has the highest proportion of Indigenous Australians (30.4%)
compared with all other Australian states or territories, in
which Indigenous Australians compose <4% of the population.
In the NT, 92% of those with RHD are Indigenous, and 85% of
those live in remote communities and towns. Indigenous
persons living in the NT have the highest reported RHD
incidence globally.13,14
Australia has a comprehensive system of recording
mortality and has produced accurate and detailed statistics
on RHD mortality for several decades.15 This system has
demonstrated a decline in total RHD death rates in Australia
over the past 4 decades; however, these RHD mortality
statistics disguise the excess mortality from RHD among
Indigenous persons because speciﬁc mortality rates are not
reported for Indigenous Australians. In addition, Indigenous
status is not always recorded, or recorded correctly, in death
registrations in most states and territories, meaning that the
number of deaths registered as Indigenous is an underesti-
mate of the actual number of deaths among the Indigenous
population. In the NT, Indigenous death identiﬁcation has
been at a consistently high level since at least 1977, meaning
that mortality rates in the Indigenous population for RHD can
be determined accurately for the NT Indigenous population
since that time.16 This study was undertaken to provide a
comprehensive examination of RHD mortality rates and trends
in Indigenous Australians.
Methods
Australia has almost complete registration of deaths and
reliable classiﬁcation of cause of death. Reliable Indigenous
identiﬁcation data have been available for the NT since 1977
and for 4 other jurisdictions since 1997 (New South Wales,
Queensland, South Australia, andWestern Australia, referred to
hereafter as the 4 states). Indigenous identiﬁcation in death
registrations remains unreliable in 3 jurisdictions (Australian
Capital Territory, Tasmania, and Victoria), which were not
included in this study. The 4 states plus the NT (the 5 states)
account for 89% of the total Australian Indigenous population.16
We undertook 3 separate analyses using vital statistics
data from Australian death certiﬁcates. The ﬁrst was a
comparison of Indigenous and non-Indigenous death rates
and time trends in RHD mortality in the NT for the 29-year
period 1977–2005. The second was a comparison of RHD
mortality for the NT Indigenous population with that of the
Indigenous population of the 4 states and with that of the
non-Indigenous population of the 5 states for the 9-year
period 1997–2005. The third was a comparison of RHD
mortality between the Indigenous and non-Indigenous popu-
lations of the 5 states for 1997–2005, including a description
of the proportion of deaths attributed to RHD as an underlying
or associated cause of death.
Statistical Analysis
We calculated the number of RHD deaths, the age-speciﬁc
death rate (in age groups 0 to 4, 5 to 24, 25 to 44, 45 to 64
and ≥65 years), and the age-adjusted death rate. The
population data used to calculate mortality rates was the
Estimated Resident Population (by Indigenous status, sex, 5-
year age group, and calendar year) of each state or territory,
published by the Australian Bureau of Statistics.17 The age
distribution of the 2001 Australian Estimated Resident
Population was used as the standard weight for calculation
of age-adjusted rates. Ratios of age-standardized death rates
are not presented because of the large differences in
mortality rate ratios between age groups. We tested for but
did not ﬁnd evidence of linearity in time trends, particularly in
terms of changes in International Classiﬁcation of Diseases
(ICD) coding.
RHD death rates for Indigenous populations were com-
pared with those for non-Indigenous populations by age group
and sex. Time trends were examined by calculating mortality
rates for 3 periods (1977–1986, 1987–1996, and 1997–
2005). Death rate ratios (DRR) were calculated using the age-
speciﬁc mortality of the NT Indigenous population compared
with the non-Indigenous population of the 5 states.
Multivariate negative binomial regression was also used to
analyze RHD mortality. The regression model for the NT
between 1977 and 2005 included terms for Indigenous status
(Indigenous compared with non-Indigenous population), age of
death (per single year of age), sex (female compared with
male), and year of death (in single calendar years) and 2
interaction terms, Indigenous status by age at death and
Indigenous status by year of death. The interaction terms
were included because the effects of age at death and year of
death were found to be different for Indigenous and non-
Indigenous persons. In the regression analysis, the term for
age at death was based at age 50 years (the median death
age), and year of death was based at 1991 (the midpoint of
the study period).
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The regression model for other analysis (ie, 1997–2005)
was the same except that age was included in 5-year age
groups and year of death was not included because analysis
of time trends was not feasible for the shorter 9-year
period.
For most analyses, we included only deaths in which the
underlying cause of death was RHD (including acute rheumatic
fever (ARF)). The underlying cause of death was coded using
ICD version 8 (until 1978), version 9 (1978–1998), and version
10 (1998 onward). Only ICD-10 death data were coded for
both associated and underlying cause of death. Death data
were not available after 2005. We undertook a separate
analysis comparing RHD as the underlying cause of death with
RHD as the associated cause of death across all 5 states to
investigate the extent to which RHD was contributing to
deaths but was not identiﬁed as the single underlying cause.
All data were analyzed using Stata software (version 11;
StataCorp). All mortality rates are expressed per
100 000 person-years. Ethics approval was granted by the
human research ethics committee of the NT Department of
Health and Menzies School of Health Research, including its
Indigenous subcommittee (HREC number 10-1488); the
human research ethics committee approved the use of
statutory death data without participant consent.
Results
RHD Mortality in the NT, 1977–2005
For the period 1977–2005, there were 280 deaths in the NT
due to RHD as the underlying cause; 253 (90%) were among
Indigenous persons, and 164 (59%) were among women. The
difference in age-speciﬁc death rates was higher for all age
groups when comparing Indigenous and non-Indigenous
persons, with the largest difference seen in the 5- to
24-year age group with a rate ratio of 43.1 (95% CI 14.7 to
143.2). For Indigenous persons, RHD death rates increased
with increasing age and were higher for women than for men
in all age groups. Non-Indigenous women had a higher death
rate than non-Indigenous men at all ages, at 19.2 compared
with 10.5, respectively, in the those aged ≥65 years (Table 1).
For non-Indigenous persons, death rates were low for all age
groups except those aged ≥65 years. The highest DRR
(206.2) was seen in Indigenous women aged 25 to 44 years.
Table 1. Northern Territory Age-Speciﬁc RHD* Deaths, 1977–2005
Sex Indigenous Non-Indigenous Rate Ratio†
Age Group, y n Rate‡ CI n Rate CI RR CI
Male
0 to 4 1 1.0 0.2 to 7.3 0 0.0 na — na
5 to 24 34 10.7 7.6 to 14.9 3 0.5 0.2 to 1.7 19.7 6.2 to 100.2
25 to 44 42 22.8 16.9 to 30.9 1 0.1 0.0 to 1.0 162.4 27.6 to 6565.8
45 to 64 20 30.1 19.4 to 46.7 4 1.2 0.4 to 3.1 26.0 8.7 to 104.8
≥65 5 31.4 13.1 to 75.4 6 10.5 4.7 to 23.1 3.0 0.7 to 11.7
Female
0 to 4 2 2.1 0.5 to 8.4 0 0.0 na — na
5 to 24 26 8.2 5.6 to 12.0 1 0.2 0.0 to 1.4 40.5 6.6 to 1659.0
25 to 44 64 33.6 26.3 to 42.9 1 0.2 0.2 to 1.2 206.2 35.7 to 8269.5
45 to 64 45 57.2 42.7 to 76.6 2 0.8 0.2 to 3.28 69.7 18.2 to 592.7
≥65 14 67.4 39.9 to 113.8 9 19.2 10.0 to 36.8 3.5 1.1 to 9.2
Persons
0 to 4 3 1.6 0.5 to 4.8 0 0.0 na — na
5 to 24 60 9.4 7.3 to 12.1 4 0.4 0.1 to 1.0 24.7 9.2 to 93.6
25 to 44 106 28.3 23.4 to 34.2 2 0.2 0.0 to 0.6 187.6 50.7 to 1568.8
45 to 64 65 44.8 35.1 to 57.1 6 1.0 0.5 to 2.3 44.0 19.2 to 124.3
≥65 19 51.8 33.0 to 81.1 15 14.2 8.7 to 23.9 3.6 1.7 to 7.5
na indicates not applicable; RHD, rheumatic heart disease.
*Underlying cause.
†Indigenous compared with non-Indigenous.
‡Per 100 000.
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Over the 29 years of the study period, a decline in the age-
adjusted death rates was evident for both Indigenous and
non-Indigenous persons. The Indigenous rate (men and
women combined) decreased from 33.5 per 100 000 in
1977–1986 to 25.3 per 100 000 in 1997–2005 (Table 2).
On multivariable analysis, the RHD death rate for women
was 34% higher than for men (Table 3). The effect of age at
death and year of death was found to be different for
Indigenous and non-Indigenous persons. For non-Indigenous
persons, RHD death rates increased by 10% per 1-year
increase in age and decreased by 7% per year between 1977
and 2005. For Indigenous persons, the increase in death rates
with year of age was much less (4% per year of age), and there
was minimal if any decrease in RHD death rates between
1977 and 2005 (DRR 0.98, 95% CI 0.97 to 1.00).
RHD Mortality in NT Indigenous Versus Other
Indigenous and Non-Indigenous Australians,
1997–2005
For the period 1997–2005, RHD death rates were much higher
for Indigenous persons in the NT than in the 4 states combined
(Figure), and both were much higher than rates for non-
Indigenous persons. Age-speciﬁc death rates were higher for
Indigenous persons in the NT than in the 4 states combined for
all age groups and for both men and women, with the largest
relative differences in the younger age groups (Table 4).
On multivariable analysis, between 1997 and 2005, the
RHD death rate (estimated at the median age of 50 years) was
much higher for Indigenous Australians in the NT (54.8 times
higher, 95% CI 41.6 to 72.3) and in the 4 states combined
(12.7 times higher, 96% CI 10.1 to 16.1) than for non-
Indigenous Australians (Table 5). The increases in death rates
with age and for women compared with men were similar for
the NT and the 4 states in both analyses.
RHD Mortality in the 5 States, 1997–2005
Between 1997 and 2005 there were 1753 deaths with RHD
as the underlying cause of death, of which 187 (10.7%) were
among Indigenous persons (69 men and 118 women) and
1157 (66%) were among women. The age-speciﬁc rates were
higher for Indigenous persons in all age groups (Table 6).
The DRR peaked in those aged 5 to 24 years and remained
considerably elevated in those aged 25 to 44 years. The
DRR remained elevated, although less so, in the older age
groups. Multivariate analysis of the 5 states (estimated at
the median age of 50 years) showed that the RHD death
rate for the Indigenous population of the 5 states combined
was 18.9 times higher than that of non-Indigenous
Australians.
RHD mortality by underlying and associated cause in
the 5 states, 1997–2005
The majority of Indigenous persons who died from RHD had
RHD recorded as the underlying cause of death rather than as
an associated cause of death; 64% of RHD deaths in the NT
and 58% in the other 4 states were among Indigenous
persons. Only a small proportion of RHD deaths in Indigenous
persons occurred in those aged ≥65 years. The opposite was
the case for non-Indigenous persons with RHD: The majority
of deaths occurred in those aged ≥65 years (81%), and among
those patients, only 17% of deaths were recorded with RHD as
the underlying cause. Overall, in the non-Indigenous popula-
tion, the majority of deaths were due to RHD as an associated
rather than an underlying cause.
Table 2. Northern Territory Rheumatic Heart Disease* Deaths by Period, 1977–2005
Indigenous Status Male Female Total
Period n Rate† CI n Rate CI n Rate CI
Indigenous
1977–1986 32 23.2 13.7 to 32.8 49 43.5 27.6 to 59.5 81 33.5 24.2 to 42.8
1987–1996 40 25.5 15.4 to 35.6 49 31.2 21.8 to 40.6 89 28.2 21.5 to 35.0
1997–2005 30 14.8 0.80 to 21.6 53 33.1 22.3 to 44.0 83 25.3 18.3 to 32.2
1977–2005 102 20.5 15.6 to 25.4 151 35.2 28.4 to 42.1 253 28.4 24.1 to 32.7
Non-Indigenous
1977–1986 6 2.9 0.0 to 5.8 6 10.6 0.1 to 21.0 12 6.9 1.3 to 12.6
1987–1996 7 2.1 0.5 to 3.8 2 1 0.0 to 2.4 9 1.6 0.5 to 2.8
1997–2005 1 0.1 0.0 to 0.4 5 2.5 0.2 to 4.9 6 1.3 0.1 to 2.6
1977–2005 14 1.3 0.6 to 2.1 13 3.1 1.2 to 4.9 27 2.3 1.3 to 2.4
*Underlying cause.
†Per 100 000.
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Discussion
Indigenous Australians are much more likely to die from RHD
than other Australians. Rates of death from RHD among
Indigenous persons in the NT exceed those of other states in
Australia and those reported in many industrialized countries
more than a century ago.18 An Indigenous person living in the
NT of Australia is 54.8 times more likely to die of RHD than a
non-Indigenous person. RHD mortality was 50% higher for
women than for men among both Indigenous and non-
Indigenous persons, and that ﬁnding is consistent with other
evidence of higher RHD mortality in women.10,19,20
The excess RHD mortality of the NT Indigenous population
(compared with the non-Indigenous population) is at least
partly due to poorer living conditions and household over-
crowding.21 Poorer access to health care for the large
proportion of the NT Indigenous population that lives in
remote areas may also play a role.22,23 These same factors
may also explain the excess RHD mortality of Indigenous
persons in the NT compared with those elsewhere in Australia;
the disparities between Indigenous and non-Indigenous
Australians in living conditions, overcrowding, and proportion
of people living in remote areas is greatest in the NT.22 Excess
mortality is mostly due to higher incidence of RHD and partly
due to more severe disease, both of which contribute to the
increased disease burden among Indigenous persons.
The disparity in the distribution of the burden of RHD
disease contributes to the gap in life expectancy of Indige-
nous persons in the NT. In recent years, a number of
initiatives have been undertaken to address this disparity
including the establishment of the NT Rheumatic Heart
Disease Register in 1996 and the commitment of the
Australian government to a seminational RHD control pro-
gram: RHDAustralia.
Increased mortality from RHD in young people is seen
elsewhere in high-prevalence, resource-poor countries,
although limited population-based mortality data are available
to quantify this observation, and further studies are
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Figure. Age-adjusted mortality rate in the period 1997–2005 for Indigenous persons in the NT compared
with Indigenous persons in the 4 states and non-Indigenous persons in the 5 states (male and female). 4
states indicates New South Wales, Queensland, South Australia, and Western Australia; 5 states, New
South Wales, Queensland, South Australia, Western Australia, and the Northern Territory; NT, Northern
Territory.
Table 3. Multivariate Analysis, Rheumatic Heart Disease
Deaths in the Northern Territory, 1977–2005
Variable Death Rate Ratio 95% CI
Indigenous status* 24.18 15.61 to 37.46
Female† 1.34 1.06 to 1.71
Age‡
Non-Indigenous 1.10 1.07 to 1.13
Indigenous 1.04 1.03 to 1.04
Year*
Non-Indigenous 0.93 0.88 to 0.97
Indigenous 0.98 0.97 to 1.00
*Estimated at the median age of 50 years in 1991.
†Compared with male.
‡Single year of age.
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required.5,24,25 A recent examination of the Fiji RHD national
register and clinical data has shown that the risk of death of
patients with RHD is increased 8.8 times compared with the
general population; this risk is greatest among young
Indigenous men (DRR 50, 95% CI 35.0 to 69.2) compared
with the non-Indigenous Fijian population.26
Over time, RHD mortality in Australia has decreased much
more for the non-Indigenous population (7.4% per year) than
for the Indigenous population (1.8% per year). Non-Indigenous
Australians were also more likely to die from other causes, with
RHD contributing as an associated, rather than the underlying,
cause of death. This example highlights how health indicators
are improving more slowly for Indigenous persons than for non-
Indigenous Australians, contributing to a widening of the gap in
health outcomes such as life expectancy. Non-Indigenous
persons were more likely to die in their elderly years of
associated-cause RHD mortality (59% of total non-Indigenous
RHD deaths were from RHD as an associated cause). RHD
deaths among Indigenous persons occurred in much larger
proportions at younger ages and as the underlying cause.
These data suggest that non-Indigenous persons are living
longer with disease and die from associated factors, possibly
because those affected with severe disease as children died
many years ago when RHD was prevalent in the non-
Indigenous population, whereas Indigenous young people are
still dying with RHD as a direct cause of disease.27,28
In the NT during the study period, the accuracy of death
certiﬁcation was high, demonstrated by studies with linked
data sets of census and mortality data.29 The accuracy of
death certiﬁcation data for the 4 other states studied is less
certain. In the NT, RHD awareness is greater than in other
jurisdictions because of the high RHD prevalence and the RHD
control program that has been in existence since the late
1990s. The NT RHD control program has seen many cases of
preexisting but undiagnosed RHD identiﬁed and registered.
This suggests that there may be similar cases in Western
Australia, Queensland, South Australia, and New South Wales
because none of those states had registers or control
programs in place during the data analysis period. There
may be people with RHD who died or whose RHD was either
Table 4. Age-Speciﬁc Rheumatic Heart Disease* Deaths in the Period1997–2005 in Indigenous Persons in the NT and the 4
States and in Non-Indigenous Persons in the 5 States
Sex NT Indigenous‡ 4 States Indigenous† 5 States Non-Indigenous
Age Group, y n Rate§ CI DRR CI n Rate CI DRR CI n Rate CI
Male
0 to 4 0 0 na 0 na 0 0 na 0 na 1 0 0.0 to 0.2
5 to 24 7 6.1 2.9 to 12.8 342.2 78.1 to 2051.0 5 0.7 0.3 to 1.7 39.6 7.7 to 255.0 3 0 0.0 to 0.1
25 to 44 17 22.5 14.0 to 36.2 193.7 95.9 to 385.4 16 3.8 2.3 to 6.1 32.3 15.8 to 65.0 21 0.2 0.1 to 0.2
45 to 64 5 18.1 7.5 to 43.5 25.8 8.2 to 62.3 13 7.2 4.2 to 12.4 10.8 5.3 to 18.4 100 0.7 0.6 to 0.9
≥65 1 18.1 2.5 to 128.2 3.0 0.1 to 17.1 5 12.7 5.3 to 30.5 2.1 0.7 to 5.0 405 5.9 5.9 to 6.5
Female
0 to 4 1 3 0.4 to 21.6 0 na 0 0 na 0 na 0 0 na
5 to 24 7 6.2 2.9 to 12.9 331.2 75.6 to 1984.8 6 0.9 0.4 to 2.0 47.4 10.1 to 292.7 3 0 0.0 to 0.1
25 to 44 22 27.9 18.4 to 42.3 168.6 92.6 to 302.1 25 5.5 3.7 to 8.2 33.4 18.8 to 58.8 30 0.2 0.1 to 0.2
45 to 64 15 46.1 27.8 to 76.5 46.9 25.5 to 80.0 19 9.8 6.3 to 15.4 10.0 5.8 to 16.2 138 1 0.8 to 1.8
≥65 8 92.5 46.6 to 184.9 9.1 3.9 to 18.1 15 29.1 17.6 to 48.3 2.9 1.6 to 4.8 865 10.1 9.5 to 10.8
Persons
0 to 4 1 1.5 0.2 to 10.5 114.8 1.5 to 9008.5 0 0 na 0 na 1 0 na
5 to 24 14 6.1 3.6 to 10.4 336.8 121.6 to 1069.2 11 0.8 0.4 to 1.4 43.1 14.7 to 143.2 6 0 na
25 to 44 39 25.2 18.4 to 34.5 179.3 115.0 to 277.4 41 4.7 3.4 to 6.3 33.1 21.4 to 51.0 51 0.1 0.1 to 0.2
45 to 64 20 33.2 21.4 to 51.5 39.5 23.7 to 62.4 32 8.7 6.1 to 12.1 10.2 6.8 to 14.8 238 0.8 0.7 to 1.0
≥65 9 63.4 33.0 to 121.9 7.7 3.5 to 14.6 20 22 14.2 to 34.1 2.7 1.6 to 4.1 1270 8.3 7.8 to 8.7
4 states indicates New South Wales, Queensland, South Australia, and Western Australia; 5 states, New South Wales, Queensland, South Australia, Western Australia, and the Northern
Territory; DRR, death rate ratio; na, not applicable; NT, Northern Territory.
*Underlying cause only.
†Four states Indigenous compared with 5 states non-Indigenous.
‡NT Indigenous compared with 5 states non-Indigenous.
§Per 100 000.
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unknown or not thought to have contributed to their death,
and this proportion may be greater in the other 4 states than
in the NT.
This study has a number of limitations relating to data
access, Indigenous identiﬁcation, and ICD coding. The most
recent year for which complete data (by year of death, not
year of registration) were available for this study was 2005
because access to Australian cause-of-death data for deaths
registered after 2007 has not been possible because of legal
and bureaucratic issues that have taken many years to
resolve. A new process to request access for research and
population health-monitoring purposes commenced in mid-
2014. We relied on vital statistics data, and cause of death
may not be perfect on death certiﬁcates.
Due to the relatively small number of deaths from RHD, the
conﬁdence intervals presented are wide (Table 1). The
difference in rates of mortality from RHD among the
Indigenous and non-Indigenous populations studied was large,
but ratios should be interpreted with this limitation consid-
ered.
The accuracy of Indigenous identiﬁcation in death data is
less reliable in the 4 states than it is in the NT, and the NT is
the only state or territory with reliable Indigenous identiﬁca-
tion since the 1970s. Indigenous identiﬁcation in death data
from the NT has a reported accuracy of 98.8%, whereas
Indigenous status in the other states’ death data may be
underestimated by 15%.30
Another factor that may have inﬂuenced the accuracy of
the data for the 29-year period in the NT were the 2 changes
Table 5. Multivariate Regression Analysis of Indigenous
Persons in the NT and the 4 States Compared With Non-
Indigenous Persons in the 5 States, 1997–2005
Variable
NT 4 States
DRR CI DRR CI
Indigenous
status*
54.80 41.58 to 72.24 12.74 10.09 to 16.09
Female† 1.52 1.35 to 1.72 1.52 1.34 to 1.71
Age
Non-
Indigenous
1.12 1.11 to 1.13 1.12 1.11 to 1.13
Indigenous 1.04 1.03 to 1.05 1.05 1.04 to 1.06
4 states indicates New South Wales, Queensland, South Australia, and Western
Australia; 5 states, New South Wales, Queensland, South Australia, Western Australia,
and the Northern Territory; DRR, death rate ratio; NT, Northern Territory.
*Base age of 50 years.
†Compared with male.
Table 6. Age-Speciﬁc Rheumatic Heart Disease Deaths and Death Rate Ratio in the 5 States*, 1997–2005
Sex Indigenous Non-Indigenous Rate Ratio
Age Group, y n Rate CI n Rate CI DRR CI
Male
0 to 4 0 0.0 na 1 0.0 0.0 to 0.2 na —
5 to 24 12 1.5 0.8 to 2.6 3 0.0 0.0 to 0.1 39.2 7.6 to 252.2
25 to 44 33 6.6 4.7 to 9.3 21 0.2 0.1 to 0.2 31.9 15.5 to 64.1
45 to 64 18 8.7 5.5 to 13.8 100 0.7 0.6 to 0.9 10.3 5.3 to 18.4
≥65 6 13.5 6.0 to 30.0 405 5.9 5.9 to 6.5 2.1 0.7 to 5.0
Female
0 to 4 1 0.9 0.1 to 2.8 0 0.0 na na —
5 to 24 13 1.6 1.0 to 2.8 3 0.02 0.0 to 0.1 46.9 10.0 to 289.7
25 to 44 47 8.9 6.7 to 11.8 30 0.17 0.1 to 0.2 33 18.6 to 58.1
45 to 64 34 15.1 10.8 to 21.1 138 0.98 0.8 to 1.2 10 5.8 to 16.2
≥65 23 38.4 25.5 to 57.9 865 10.13 9.5 to 10.8 2.9 1.6 to 4.8
Persons
0 to 4 1 0.19 0.0 to 1.4 1 0.0 na — —
5 to 24 25 1.55 1.0 to 2.3 6 0.0 na 39.2 7.6 to 252.2
25 to 44 80 7.75 6.2 to 9.7 51 0.1 0.1 to 0.2 31.9 15.6 to 64.2
45 to 64 52 12.04 9.2 to 15.8 238 0.84 0.7 to 1.0 10.3 5.3 to 18.4
≥65 29 27.76 19.9 to 40.0 1270 8.26 7.8 to 8.7 2.1 0.7 to 5.0
DRR indicates death rate ratio; na, not applicable.
*Underlying cause.
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in ICD coding. In 1997 there was a change in ICD coding from
ICD-9 to ICD-10, which resulted in some artifactual variation
in disease coding. The comparability with ICD-9 has been
assessed by the Australian Bureau of Statistics.31,32 Changes
in coding may contribute to an underestimation of mortality
rate and may falsely suggest a decline. The change in ICD-10
coding appears to have produced a step in the decline in
mortality from 1997 to 1999, but we found that the effect of
the change in coding was less than expected and did not
appear to produce a statistically signiﬁcant change.
There were inherent limitations in the multivariate analysis
model. The model makes assumptions that the linear effect of
age and time and the effect for all predictors are assumed to
be constant over time, except for the effect of Indigenous
status. Our model, however, did not account for the change
over time in the relative rates for various age categories or for
sex.
This mortality study provided a comprehensive review of
RHD mortality in Australia, with a focus on understanding the
disparity in mortality between Indigenous and non-Indigenous
populations. As shown by the 2005 study of the global burden
of group A streptococcal disease7 and the recent Global
Burden of Disease Study 2010,33 very few RHD data are
available to measure actual RHD in either high- and low-preva-
lence regions. Current published global mortality estimates are
based largely on estimates extrapolated from expected
numbers of deaths of persons living with RHD, not on vital
statistics or register-based mortality data. Further research is
required to determine the rates of RHD mortality in Indigenous
populations of developed countries and in developing coun-
tries with known high prevalence of RHD.
Sources of Funding
This research was undertaken as part of Dr. Colquhoun’s
doctoral work. No additional funding was sourced to under-
take this study.
Disclosures
None.
References
1. Comparing life expectancy of indigenous people in Australia, New Zealand,
Canada and the United States: conceptual, methodological and data issues.
Australian Institute of Health and Welfare 2011. Cat. no. 47. Canberra: AIHW.
2. Gunther G, Asmera J, Parry E. Death from rheumatic heart disease in rural
Ethiopia. Lancet. 2006;367:391.
3. Craig E, McDonald G, Wicken A, Reddington A, Tafua S. The determinants of
health for Paciﬁc children and young people in New Zealand. New Zealand
Child and Youth Epidemiology Service. University of Otago; 2010.
4. Carapetis JR, Currie BJ. Mortality due to acute rheumatic fever and rheumatic
heart disease in the Northern Territory: a preventable cause of death in
aboriginal people. Aust N Z J Public Health. 1999;23:159–163.
5. Oli K, Asmera J. Rheumatic heart disease in Ethiopia: could it be more
malignant? Ethiop Med J. 2004;42:1–8.
6. Kumar R, Raizada A, Aggarwal AK, Ganguly NK. A community-based rheumatic
fever/rheumatic heart disease cohort: twelve-year experience. Indian Heart J.
2002;54:54–58.
7. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A
streptococcal diseases. Lancet Infect Dis. 2005;5:685–694.
8. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J,
Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews
KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ,
Bennett D, Bhalla K, Bikbov B, Abdulhak AB, Birbeck G, Blyth F, Bolliger I,
Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh
SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD,
Cooper LT, Corriere M, Cortinovis M, Courville de Vaccaro K, Couser W, Cowie
BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt
L, Delossantos A, Denenberg J, Jarlais DCD, Dharmaratne SD, Dorsey ER,
Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman
AD, Forouzanfar MH, Fowkes FGR, Franklin R, Fransen M, Freeman MK, Gabriel
SE, Gakidou E, Chem FG, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D,
Harrison JE, Rasmus Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen
KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum
N, Keren A, Khoo J-P, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi
R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L,
March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM,
McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud
C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland
K, Nair MN, Naldi L, Narayan KMV, Nasseri K, Norman P, O’Donnell M, Omer
SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla
RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope AC, III, Porrini E,
Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP,
Roberts T, Rodriguez De Leon F, Rosenfeld LC, Rushton L, Sacco RL, Salomon
JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh
D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM,
Towbin JA, Truelsen T, Eduardo A, Undurraga EA, Venketasubramanian N,
Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA,
Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh P-H, Yip P, Zabetian A, Zheng
Z-J, Lopez AD, Murray CJL. Global and regional mortality from 235 causes of
death for 20 age groups in 1990 and 2010: a systematic analysis for the
Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128.
9. AIHW, Penm E. Cardiovascular disease and its associated risk factors in
Aboriginal and Torres Strait Islander peoples 2004–05. Cardiovascular disease
series no. 29. Cat. no. CVD 41. Canberra: AIHW; 2008.
10. Northern Territory Health Outcomes Report: Morbidity and Mortality
1979–1991. NT Department of Health and Community Services; 1995.
11. MacDonald M, Brown A, Noonan S. Preventing recurrent rheumatic fever: the
role of register based programmes. Heart. 2005;91:1131–1133.
12. The Health andWelfare of Australia’s Aboriginal and Torres Strait Islander Peoples.
Canberra: Australian Institute of Health and Welfare; 2010. Contract No: 4704.
13. Carapetis JR, Currie BJ. Clinical epidemiology of rheumatic fever and rheumatic
heart disease in tropical Australia. Adv Exp Med Biol. 1997;418:233–236.
14. Carapetis JR, Wolff DR, Currie BJ. Acute rheumatic fever and rheumatic heart
disease in the top end of Australia’s Northern Territory. Med J Aust.
1996;164:146–149.
15. Australian Institute of Health and Welfare (AIHW). GRIM (General Record of
Incidence of Mortality) Books. Canberra: AIHW; 2008.
16. Australian Bureau of Statistics Experimental Estimates of Aboriginal and Torres
Strait Islander Australians. Canberra. 2006. Contract No: 3238.0.55.001.
17. Information Paper: External Causes of Death: Data Quality 2005. Canberra:
Australian Bureau of Statistics; 2007. Catalogue no.3317.055.001. Available
at: http://www.abs.gov.au/ausstats/abs@.nsf/mf/3317.0.55.001.
18. Mortality and Morbidity: Cardiovascular Disease: 20th Century Trends.
Australian Social Trends: Contract no: 4102.0. Canberra: Australian Bureau
of Statistics; 2002.
19. Assessment of methods for developing life tables. Australian Bureau of
Statistics. Discussion Paper. Canberra: 2002. Contract no. 3302.0.55.002.
20. Haddad N, Silva MB. Mortality due to cardiovascular disease in women during
the reproductive age (15 to 49 years), in the State of Sao Paulo, Brazil, from
1991 to 1995. Arq Bras Cardiol. 2000 Nov;75:375–379.
21. McDonald MI, Towers RJ, Andrews R, Benger N, Fagan P, Currie BJ, Carapetis
JR. The dynamic nature of group A streptococcal epidemiology in tropical
communities with high rates of rheumatic heart disease. Epidemiol Infect.
2008;136:529–539.
22. Biddle N, Yap M. Demographic and Socioeconomic Outcomes Across the
Indigenous Australian Lifecourse: Evidence From the 2006 Census. Canberra:
Centre of Aboriginal Economic Policy Research, Australian National University;
2010. Contract No: 31.
DOI: 10.1161/JAHA.114.001282 Journal of the American Heart Association 8
Indigenous Rheumatic Heart Disease Mortality Colquhoun et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on O
ctober 25, 2016
http://jaha.ahajournals.org/
D
ow
nloaded from
 
23. Closing the Gap Clearinghouse (AIHW, AIFS) 2012. What works to overcome
Indigenous disadvantage: key learnings and gaps in the evidence 2010–11.
Produced for the Closing the Gap Clearinghouse. Canberra: Australian Institute
of Health and Welfare & Melbourne: Australian Institute of Family Studies.
24. Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence
and characteristics of newly diagnosed rheumatic heart disease in urban
African adults: insights from the heart of Soweto study. Eur Heart J.
2010;31:719–727.
25. Milne RJ, Lennon D, Stewart JM, Vander Hoorn S, Scuffham PA. Mortality and
hospitalisation costs of rheumatic fever and rheumatic heart disease in New
Zealand. J Paediatr Child Health. 2012;48:692–697.
26. Parks T, Kado J, Miller AE, Ward B, Heenan RC, Colquhoun SM, Tukana I, Steer
A. Mortality amongst patients with rheumatic heart disease in Fiji: a national
historic data-linkage cohort study. Glob Heart J. 2014;9:158.
27. Lawrence JG, Carapetis JR, Grifﬁths K, Edwards K, Condon JR. Acute rheumatic
fever and rheumatic heart disease incidence and progression in the Northern
Territory of Australia, 1997 to 2010. Circulation. 2013;128:492–501.
28. Brown A, McDonald MI, Calma T. Rheumatic fever and social justice. Med J
Aust. 2007;186:557–558.
29. Australian Bureau of Statistics Census Data Enhancement—Indigenous Mortality
Quality Study 2006–07. Canberra: 2008. Contract No: 4723.
30. Australian Bureau of Statistics. Discussion Paper: Assessment of Methods for
Developing Life Tables for Aboriginal and Torres Strait Islander Australians,
2006. Cat. no. 3302.0.55.002.
31. Zhao YD, Dempsey K. Causes of inequality in life expectancy between
Indigenous and non-Indigenous people in the Northern Territory, 1981–2000:
a decomposition analysis. Med J Aust. 2006;184:490–494.
32. Australian Bureau of Statistics. Australian Standard Geographical Classiﬁca-
tion (ASGC), July 2010. No. 1216.0. Available at: http://www.abs.gov.au/
AUSSTATS/abs@.nsf/Lookup/1216.0Main+Features1July%202010.
33. Colquhoun S, Karthikeyan G, Condon J, Mayosi B, Steer A, Parks T, Mensah G,
Forouzanfar M, Ezzati M, Carapetis J. The global burden of rheumatic heart
disease: the tip of the iceberg. Glob Heart J. 2014;9:158.
DOI: 10.1161/JAHA.114.001282 Journal of the American Heart Association 9
Indigenous Rheumatic Heart Disease Mortality Colquhoun et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on O
ctober 25, 2016
http://jaha.ahajournals.org/
D
ow
nloaded from
 
Jonathan R. Carapetis
Samantha M. Colquhoun, John R. Condon, Andrew C. Steer, Shu Q. Li, Steven Guthridge and
Disparity in Mortality From Rheumatic Heart Disease in Indigenous Australians
Online ISSN: 2047-9980 
Dallas, TX 75231
 is published by the American Heart Association, 7272 Greenville Avenue,Journal of the American Heart AssociationThe 
doi: 10.1161/JAHA.114.001282
2015;4:e001282; originally published July 28, 2015;J Am Heart Assoc. 
 http://jaha.ahajournals.org/content/4/7/e001282
World Wide Web at: 
The online version of this article, along with updated information and services, is located on the
 
 for more information. http://jaha.ahajournals.orgAccess publication. Visit the Journal at 
 is an online only OpenJournal of the American Heart AssociationSubscriptions, Permissions, and Reprints: The 
 by guest on O
ctober 25, 2016
http://jaha.ahajournals.org/
D
ow
nloaded from
 
